Ironwood製藥 IRWD 深 滬
等待開盤 07-18 09:30:00 美东时间
0.7908
+0.051
+6.91%
華盛通- 最 高0.82
- 今 開0.7394
- 成交量 113.85万股
- 最 低 0.7346
- 昨 收 0.7397
- 總市值 1.28亿
- 52周最高 7.10
- 市盈率 靜 143.78
- 換手率 0.70%
- 52周最低 0.5271
- 委 比 63.91%
- 總股本 1.62亿
- 歷史最高 18.915
- 量 比 1.03
- 振 幅 11.55%
- 歷史最低 0.5271
- 每 手 1
- 風險率 3.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Ironwood Pharmaceuticals (NASDAQ:IRWD) stock rose 15.2% to $0.71 durin...
06-14 05:05
美股大行评级 | 潜在涨幅684.71%！Verve Therapeutics获Canaccord Genuity升目标价至39美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Verve Therapeutics(VERV)"买入"评级，目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.：维持Verve Ther
04-16 09:45
Trump targets Medicare price negotiations in new executive order
President Donald Trump on Tuesday signed an executive order to lower prescription drug prices through a series of measures, including a requirement to change a key provision in the Medicare drug price...
04-16 08:23
Ironwood downgraded at Jefferies on apraglutide-related challenges
Ironwood Pharmaceuticals (NASDAQ:IRWD) has been downgraded to Hold from Buy at Jefferies after the company announced pressures related to its lead asset, apraglutide. The company announced Monday tha...
04-16 00:10
Jefferies Downgrades Ironwood Pharmaceuticals to Hold, Lowers Price Target to $0.7
Jefferies analyst Amy Li downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) from Buy to Hold and lowers the price target from $8 to $0.7.
04-15 19:50
美股大行评级 | 潜在涨幅506.8%！HC Wainwright & Co.上调Verve Therapeutics目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1118823510909566976.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Verve Therapeutics(VERV)"买入"评级，目标价从15美元升至25美元</p> <p>• Piper Sandler：维持LENZ Therapeut
04-15 11:35
Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug
Ironwood must run a new Phase 3 trial after FDA talks, delaying its SBS drug approval despite strong results from prior studies.
04-15 02:19
Ironwood Pharma (IRWD) Receives a Buy from Craig-Hallum
Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Ironwood Ph...
04-14 21:06
Ironwood Pharma Delays 10-K Filing Due to Internal Issues
Ironwood Pharma ( ($IRWD) ) has released a notification of late filing. Ironwoo...
03-04 06:20
